CB Scientific (CBSC) Stock Statistics & Valuation Metrics
Total Valuation
CB Scientific has a market cap or net worth of $5.05M. The enterprise value is $4.42T.
- Market Cap
- $5.05M
- Enterprise Value
- $4.42T
Share Statistics
CB Scientific has 165,438,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 165,438,570
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
CB Scientific’s return on equity (ROE) is 0.39 and return on invested capital (ROIC) is 97.10%.
- Return on Equity (ROE)
- 0.39
- Return on Assets (ROA)
- -1.81
- Return on Invested Capital (ROIC)
- 97.10%
- Return on Capital Employed (ROCE)
- 0.67
- Revenue Per Employee
- 38.18K
- Profits Per Employee
- -223.99K
- Employee Count
- 4
- Asset Turnover
- 0.31
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CB Scientific is -7.05. CB Scientific’s PEG ratio is -0.07.
- PE Ratio
- -7.05
- PS Ratio
- 34.70
- PB Ratio
- -2.32
- Price to FCF
- -7.46
- Price to Operating Cash Flow
- -7.51
- PEG Ratio
- -0.07
Income Statement
In the last 12 months, CB Scientific had revenue of 152.73K and earned -895.97K in profits. Earnings per share was -0.01.
- Revenue
- 152.73K
- Gross Profit
- 0
- Operating Income
- -1.16M
- Pretax Income
- -895.97K
- Net Income
- -895.97K
- EBITDA
- -1.16M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -687.43K and capital expenditures -4, giving a free cash flow of -687.43K billion.
- Operating Cash Flow
- -687.43K
- Free Cash Flow
- -687.43K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
CB Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.40%
- Earnings Yield
- -16.56%
Stock Price Statistics
- Beta
- 1.02
- 52-Week Price Change
- -31.82%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 26.33
- Average Volume (3m)
- 52.40K
Financial Position
CB Scientific as a current ratio of 0.22, with Debt / Equity ratio of -23.43%
- Current Ratio
- 0.22
- Quick Ratio
- 0.15
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- -0.46
- Interest Coverage Ratio
- -4.57
Taxes
In the past 12 months, CB Scientific has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CB Scientific EV to EBITDA ratio is -4.84, with an EV/FCF ratio of -8.22.
- EV to Sales
- 38.25
- EV to EBITDA
- -4.84
- EV to Free Cash Flow
- -8.22
- EV to Operating Cash Flow
- -8.22
Balance Sheet
CB Scientific has $2,065.00 in cash and marketable securities with $527.50K in debt, giving a net cash position of -$525.43K billion.
- Cash & Marketable Securities
- $2,065.00
- Total Debt
- $527.50K
- Net Cash
- -$525.43K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.01
Margins
Gross margin is 0.00%, with operating margin of -725.51%, and net profit margin of -578.04%.
- Gross Margin
- 0.00%
- Operating Margin
- -725.51%
- Pretax Margin
- -569.92%
- Net Profit Margin
- -578.04%
- EBITDA Margin
- -790.71%
- EBIT Margin
- -790.71%
Analyst Forecast
The average price target for CB Scientific is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 97.37%
- EPS Growth Forecast
- 48.51%